Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

management in evaluating the performance of Schering-Plough's overall business. The effects of purchase accounting adjustments, special and acquisition-related items and other specified items have been excluded from Net income available to common shareholders and Diluted earnings per common share as management of Schering-Plough does not consider these items to be indicative of continuing operating results. Schering-Plough believes that these "As Reconciled" performance measures contribute to a more complete understanding by investors of the overall results of the company and enhances investor understanding of items that impact the comparability of results between fiscal periods. Net income available to common shareholders and Diluted earnings per common share, as reported, are required to be presented under U.S. GAAP.

Three months ended September 30, 2008

(unaudited)

-------------------------------------------------------

Special and

Purchase Acquisition- Other As

As Accounting Related Specified Reconciled

Reported Adjustments Items Items (1)

-------------------------------------------------------

Net sales $4,576 $- $- $- $4,576

Cost of sales 1,737 (221) - - 1,516

Selling, general

and administrative 1,660 (1) - - 1,659

Research and

development 893 (3) - - 890

Other expense/

(income), net (39) - - 160 121

Special and

acquisition-related

charges 101 - (101) - -


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Triangle Park, NC (PRWEB) June 19, 2013 ... Entegrion , Inc., announced organizational changes to advance ... John B. Mowell said, “To support the advanced ... Directors has made changes to the Company’s management ... , The Company announced that Michael ...
(Date:6/19/2013)... 2013 PREFERRED Therapy Providers, Inc. (PREFERRED) ... to offer a new Medicare Advantage Plan for ... Yavapai and Mohave, Arizona counties. The agreement takes effect ... January 1, 2013 and Maricopa and Pima counties will ... the parent company of WellCare of Arizona has Medicare ...
(Date:6/19/2013)... 2013 Alternatives, a revolutionary new treatment ... quit using drugs while allowing them to continue drinking ... of Alternatives, believe that abstinence-only approaches force people to ... and that this approach hurts instead of helping. ... United States need treatment for addiction but only 3 ...
(Date:6/19/2013)... 2013 At a Travel Services Member Conference, ... growth that has occurred over the last year since he ... said, "Travel Services has added vendors, lowered prices of travel ... Membership is up, even in the tough economy, and they've ... members." , Having been in the Travel Business and Timeshare ...
(Date:6/19/2013)... In 2011, the value of the ... Generic drugs form the largest sector, accounting for nearly ... industry is a significant contributor to the local economy; ... Approximately 50% of the total domestic chemical industry output ... Galenika and Zdravlje Actavis are key participants in the ...
Breaking Medicine News(10 mins):Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... 1, 2010) While health policy researchers commonly suggest ... provided can be attributed to hospital costs or physician ... a specific surgical procedure minimally invasive aneurysm repair ... Researchers at Cedars-Sinai Medical Center in Los Angeles have ...
... ... on simple, healthier cooking while offering time and stress relief at home , ... (PRWEB) April 2, 2010 -- As the ... TV shows and White House campaigns – Dream Dinners , Inc. today announced the ...
... ... ... Tahitian Noni® International (TNI) have revealed that the noni fruit is also ... body to adapt to stress. Noni assists resistance to a broad range of negative physical, ...
... ... the new work selection process that virtually guarantees that people will discover, ... more completely than ever before. These are the jobs that best match ... both employees and owners will be greatly rewarded for the valued results ...
... ... Sale , ... (PRWEB) April 2, 2010 -- New Chapter Press announced that the newly-updated memoir ... today and is now available in book stores and via internet book retailers in North ...
... ... Denial, , ... -- Every year, Sokolove Law hears from thousands of consumers who believe they have been ... a policyholder who has a legitimate claim. In response to this growing “bad faith” ...
Cached Medicine News:Health News:Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms 2Health News:Dream Dinners Launches Nationwide Program to Help Families Eat Healthier 2Health News:Dream Dinners Launches Nationwide Program to Help Families Eat Healthier 3Health News:Adaptogenic Properties of Tahitian Noni Bioactive Beverages Revealed 2Health News:Go to Play Every Day & Call it Work: Finally-The Book to Get the Best Jobs For Everyone 2Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 2Health News:Rod Laver Memoir 'The Education Of A Tennis Player' Officially Released By New Chapter Press 3Health News:Sokolove Law Helps Thousands of Consumers Fight Unfair Disability Insurance Denial 2Health News:Sokolove Law Helps Thousands of Consumers Fight Unfair Disability Insurance Denial 3
(Date:6/19/2013)... Ala. , June 19, 2013 DST ... solutions and services to health plans, integrated delivery systems, ... its Medical Drug Management Service (MDMS) has ... clinically edit and automate the pricing of medical prescription ... gain efficiencies by automating their medical drug claims processes. ...
(Date:6/19/2013)... N.J. , June 19, 2013 /PRNewswire-iReach/ ... Pharma, a new specialty pharmaceutical company dedicated ... of innovative injectable and sustained release drug ... unmet medical needs, today announced the acquisition ... Linker Technology®) platform and associated product pipeline. ...
(Date:6/19/2013)... Pharma IQ is pleased to announce ... of the results from an industry survey conducted earlier this ... that CROs would be an area of active investment in ... 6 or more clinical trials in the BRIC region. The ... USA Summit explores the latest trends, challenges ...
Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 2Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 3Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 4Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 5Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 6Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 7Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 8
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: